[Emergency management of acute angioedema]
- PMID: 20461661
- DOI: 10.1055/s-0030-1253694
[Emergency management of acute angioedema]
Abstract
Angioedema is an oedematous swelling of the mucosa or submucosa of the skin. Acute angioedema represents a clinical emergency when the pharynx or larynx are involved and breathing of the patient is impaired. For rapid and effective treatment it is necessary to differentiate between allergic and non-allergic angioedema. Three of the five subforms of non-allergic angioedema are mediated by bradykinin: renin-angiotensin-aldosterone system (RAAS)-blocker-induced angioedema (RAE), hereditary angioedema (HAE) and acquired angioedema (AAE). Antihistamines, corticosteroids and adrenalin can be used to treat allergic angioedema but are ineffective in acute attacks of non-allergic angioedema. In these events the bradykinin-B2-receptor antagonist icatibant (in HAE, or RAE) or C1-INH concentrate (in HAE, or AAE) are therapeutic options for rapid alleviation of acute angioedema. The following article gives an overview of the diagnostics and treatment in the emergency situation of "acute angioedema", especially if swelling of the head-and-neck region is present.
Georg Thieme Verlag KG Stuttgart * New York.
Similar articles
-
Nonallergic angioedema: role of bradykinin.Allergy. 2007 Aug;62(8):842-56. doi: 10.1111/j.1398-9995.2007.01427.x. Allergy. 2007. PMID: 17620062 Review.
-
Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.Clin Exp Immunol. 2017 Apr;188(1):148-153. doi: 10.1111/cei.12910. Epub 2017 Feb 9. Clin Exp Immunol. 2017. PMID: 27936514 Free PMC article.
-
Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence?Int J Clin Pract. 2005 May;59(5):594-9. doi: 10.1111/j.1742-1241.2005.00352.x. Int J Clin Pract. 2005. PMID: 15857357 Review.
-
Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).J Allergy Clin Immunol. 2007 Jun;119(6):1497-503. doi: 10.1016/j.jaci.2007.02.012. Epub 2007 Apr 5. J Allergy Clin Immunol. 2007. PMID: 17418383 Clinical Trial.
-
Successful long-term treatment with the bradykinin B2 receptor antagonist icatibant in a patient with hereditary angioedema.Int J Dermatol. 2011 Oct;50(10):1294-5. doi: 10.1111/j.1365-4632.2011.05051.x. Int J Dermatol. 2011. PMID: 21950301
Cited by
-
[Bradykinin-induced angioedema: Definition, pathogenesis, clinical presentation, diagnosis and therapy].HNO. 2015 Dec;63(12):885-93; quiz 894-5. doi: 10.1007/s00106-015-0084-8. HNO. 2015. PMID: 26597136 German.
-
The role of bradykinin receptor type 2 in spontaneous extravasation in mice skin: implications for non-allergic angio-oedema.Br J Pharmacol. 2018 May;175(10):1607-1620. doi: 10.1111/bph.14166. Epub 2018 Apr 14. Br J Pharmacol. 2018. PMID: 29465763 Free PMC article.
-
Angioedema in the emergency department: a practical guide to differential diagnosis and management.Int J Emerg Med. 2017 Dec;10(1):15. doi: 10.1186/s12245-017-0141-z. Epub 2017 Apr 13. Int J Emerg Med. 2017. PMID: 28405953 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical